Dr. Anne Mullin works with leading decision-makers across the HealthSphere to amplify the impact of biomedical discoveries and healthcare innovations on the health and wellbeing of populations in both developed and developing countries.
Dr. Mullin’s collaborative approach to working with clients and rich academic track record in the study of infectious disease have supported the sustainability and success of numerous international product development consortia, allowed both industry and academic partners to manage risk of high-impact clinical trials, and helped clients from industry, academia and the not-for-profit sector attract capital, establish partnerships and drive innovation. Having led engagements in North America, Europe, Southeast Asia and Africa, Anne’s client base spans the globe.
Prior to joining Shift Health, Dr. Mullin was a postdoctoral fellow and lecturer in the department of Pathology and Laboratory Medicine at the University of British Columbia. While at UBC, she was also a committed leader in the public communication of science within British Columbia and Director of the Society for Canadian Women in Science and Technology. Dr. Mullin graduated with a MSc from the London School of Hygiene and Tropical medicine, a PhD in virology from The University of Cambridge and an MBA from the Richard Ivey School of Business, where she specialized in healthcare and life sciences strategy.